Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

NCT01166204 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Stage I-III Non-small Cell Lung Cancer

Interventions

RADIATION: Radiotherapy

Sponsor

Maastricht Radiation Oncology